Emily S Ford

5PUBLICATIONS
48CO-AUTHORS
Epidemiological modellingEpigenetics (incl. genome methylation and epigenomics)Disease surveillanceRegenerative medicine (incl. stem cells)Infectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 19, 2026
First report on remdesivir use for the treatment of respiratory syncytial virus in five allogeneic hematopoietic cell transplant recipients.

|Aug 08, 2025
TCR2HLA: calibrated inference of HLA genotypes from TCR repertoires enables identification of immunologically relevant metaclonotypes.

Koshlan Mayer-Blackwell, Anastasia Minervina, Mikhail Pogorelyy

|May 13, 2025
Epidemiology of Healthcare Facility-Associated Nontuberculous Mycobacteria From 2012 Through 2020 in a 10-Hospital Network in the United States.

Arthur W Baker, Ricardo M La Hoz, Judith A Anesi

|Dec 06, 2023
Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19.

Emily S Ford, Koshlan Mayer-Blackwell, Lichen Jing

|Nov 03, 2022
Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir.

Emily S Ford, William Simmons, Ellora N Karmarkar

Pageof 1

Frequent Collaborators

2 joint publications

David M Koelle

2 joint publications

Andrew Fiore-Gartland

1 joint publications

Kerry J Laing

1 joint publications

Anton M Sholukh